IN-VITRO STIMULATION OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS (PBMC) FROM HIV- AND HIV+ CHANCROID PATIENTS BY HAEMOPHILUS-DUCREYI ANTIGENS

被引:0
|
作者
VANLAER, L
VINGERHOETS, J
VANHAM, G
KESTENS, L
BWAYO, J
OTIDO, J
PIOT, P
ROGGEN, E
机构
[1] INST TROP MED, DEPT INFECT & IMMUN, PATHOL & IMMUNOL LAB, B-2000 ANTWERP, BELGIUM
[2] UNIV NAIROBI, COLL HLTH SCI, DEPT MED MICROBIOL, NAIROBI, KENYA
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 1995年 / 102卷 / 02期
关键词
CHANCROID; HAEMOPHILUS DUCREYI; CELLULAR IMMUNE RESPONSE; HIV;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The cellular immune responses to fractionated Haemophilus ducreyi antigens, coated on latex beads, were assessed in patients with chancroid and in controls, using an in vitro lymphocyte proliferation assay. Several fractions of H. ducreyi antigen revealed stimulating activity. However, only the molecular size ranges 91-78 kD, 59-29 kD, and 25-21 kD induced proliferation that may be specifically related to H. ducreyi infection. Lymphocytes from four HIV- patients, successfully treated for chancroid, were not stimulated by H. ducreyi antigen. In general, lymphocytes from HIV+ chancroid patients were less responsive to H. ducreyi antigen compared with those from HIV- chancroid patients. However, two HIV-infected patients showed exceptionally strong responses to high molecular weight fractions. To our knowledge this is the first report demonstrating that H. ducreyi contains specific T cell-stimulating antigens. Based on this work, further identification and purification of the T cell antigens is feasible.
引用
收藏
页码:243 / 250
页数:8
相关论文
共 50 条
  • [21] DIMINISHED EXPRESSION OF CELL-SURFACE COMPLEMENT REGULATORY PROTEINS IN HIV-INFECTED CHILDREN AND WITH HIV-INFECTION OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS IN-VITRO
    JARVIS, JN
    TAYLOR, H
    LONG, PM
    GUTTA, PV
    POUSAK, T
    FINE, N
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1995, 9 (03) : 249 - 256
  • [22] Improvement of the lymphoproliferative immune response and apoptosis inhibition upon in vitro treatment with zinc of peripheral blood mononuclear cells (PBMC) from HIV+ individuals
    Neves, I
    Bertho, AL
    Veloso, VG
    Nascimento, DV
    Campos-Mello, DLA
    Morgado, MG
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1998, 111 (02): : 264 - 268
  • [23] HIV GENOME IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF SERONEGATIVE REGULAR SEXUAL PARTNERS OF HIV-INFECTED SUBJECTS
    PEZZELLA, M
    MANNELLA, E
    MIROLO, M
    VONESCH, N
    MACCHI, B
    ROSCI, MA
    MICELI, M
    MORACE, G
    RAPICETTA, M
    ANGELONI, P
    SORICE, F
    JOURNAL OF MEDICAL VIROLOGY, 1989, 28 (04) : 209 - 214
  • [25] PRODUCTION OF NITRIC-OXIDE FROM PERIPHERAL-BLOOD MONONUCLEAR-CELLS AND POLYMORPHONUCLEAR LEUKOCYTES OF PATIENTS WITH HIV-1
    TORRE, D
    FERRARIO, G
    BONETTA, G
    SPERANZA, F
    ZEROLI, C
    AIDS, 1995, 9 (08) : 979 - 980
  • [26] NONSENSE MUTATIONS IN THE VPR GENE OF HIV-1 DURING IN-VITRO VIRUS PASSAGE AND IN HIV-1 CARRIER-DERIVED PERIPHERAL-BLOOD MONONUCLEAR-CELLS
    NAKAYA, T
    FUJINAGA, K
    KISHI, M
    OKA, S
    KURATA, T
    JONES, IM
    IKUTA, K
    FEBS LETTERS, 1994, 354 (01) : 17 - 22
  • [27] MITOGEN RESPONSES OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM ANUG PATIENTS
    LEE, DR
    DENNISON, DK
    JOURNAL OF DENTAL RESEARCH, 1987, 66 : 317 - 317
  • [28] RESPONSES TO SUPERANTIGENS OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM PATIENTS WITH PSORIASIS
    YOKOTE, R
    FURUKAWA, F
    TOKURA, Y
    YAGI, H
    TAKIGAWA, M
    CLINICAL RESEARCH, 1994, 42 (01): : A41 - A41
  • [29] SUPPRESSION OF IMMUNE-RESPONSE IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS (PBMC) OF TESTICULAR CANCER-PATIENTS
    COBLEIGH, M
    BENSON, M
    EINHORN, L
    ROHN, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 377 - 377
  • [30] QUANTIFICATION OF CYTOKINE MESSENGER-RNA IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS (PBMC) OF PATIENTS WITH SEVERE ASTHMA
    DOI, S
    GEMOUENGESAETH, V
    KAY, AB
    CORRIGAN, CJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (01) : 253 - 253